NEW YORK, April 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TechTarget, Inc. ("TechTarget" or the "Company") (NASDAQ: TTGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether TechTarget and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.[Click here for information about joining the class action]On April 18, 2025, T ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving Methanex Corporation and its officers or directors [1]. Group 1: Company Performance and Events - On March 9, 2025, Methanex announced an unplanned outage at its 1.8 million tonne methanol plant, Geismar 3, in Louisiana, which occurred in late February [3]. - Following the outage announcement, Methanex's management decided to repair the autothermal reformer (ATR) and estimated a plant startup by early May 2025 [3]. - The stock price of Methanex fell by $5.45 per share, or 12.9%, closing at $36.80 per share on March 10, 2025, after the announcement [4]. Group 2: Legal and Regulatory Context - Pomerantz LLP, a firm known for its work in corporate, securities, and antitrust class litigation, is leading the investigation into Methanex [5]. - The firm has a history of recovering multimillion-dollar damages for victims of securities fraud and corporate misconduct [5].

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Allbirds, Inc. (“Allbirds” or the “Company”) (NASDAQ: BIRD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Allbirds and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On March 11, ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving OSI Systems, Inc. and its executives [1] Group 1: Investigation and Allegations - The investigation by Pomerantz LLP is focused on whether OSI and certain officers or directors have engaged in securities fraud [1] - Culper Research published a report alleging that OSI's growth in Mexico revenues is "largely an illusion" and criticized the company for downplaying investigations by the U.S. Department of Justice [3] - Following the release of the short report, OSI's stock price decreased by $6.35, or 3.5%, closing at $175.31 per share on March 13, 2025 [3] Group 2: Company Background - OSI Systems, Inc. is publicly traded on NASDAQ under the ticker OSIS [1] - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering significant damages for victims of securities fraud [4]

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving XP Inc. and its officers or directors [1] Group 1: Investigation and Allegations - Pomerantz LLP is representing investors of XP Inc. in an investigation regarding possible securities fraud [1] - Grizzly Research published a report alleging that XP is operating a Ponzi scheme through derivatives sales misrepresented as proprietary trading profits [3] - Following the report's release, XP's stock price decreased by $0.82, or 5.48%, closing at $14.14 per share on March 12, 2025 [3] Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering significant damages for victims of securities fraud [4]

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Bitfarms Ltd. (“Bitfarms” or the “Company”) (NASDAQ: BITF).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bitfarms and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On December 9, ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices by The Vita Coco Company, Inc. following allegations of misleading investors regarding its growth and operations [1][3]. Group 1: Allegations and Investigations - NINGI Research published a report on March 26, 2025, alleging that Vita Coco misled investors about its growth and operations, including the potential loss of a key contract with Costco, which accounts for approximately 25% of its net sales [3]. - The report also highlights internal operational issues at Vita Coco, such as supply chain mismanagement, related-party transactions, and underperformance outside its core coconut water business [3]. Group 2: Market Reaction - Following the release of the allegations, Vita Coco's stock price experienced a significant decline, falling by $3.90 per share, or 11%, to close at $31.55 per share on March 26, 2025 [4].

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Endeavour and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Apr ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Adverum Biotechnologies, Inc. following the company's announcement of the need to restate its financial statements due to accounting errors [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of Adverum and is looking into claims of securities fraud or other unlawful practices by the company and its officers or directors [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the class action [2]. Group 2: Financial Disclosure - On March 31, 2025, Adverum disclosed that certain previously issued financial statements should no longer be relied upon due to non-cash errors related to tenant improvement allowances for an operating lease in North Carolina [3]. - The company announced it will restate its financial statements for the years ended December 31, 2022, and 2023, as well as for the quarterly periods in 2023 and 2024 [3]. - Following this announcement, Adverum's stock price dropped by $0.54 per share, a decline of 12.36%, closing at $3.83 per share on April 1, 2025 [3].

Core Viewpoint - Northrop Grumman Corporation is under investigation for potential securities fraud and unlawful business practices following disappointing financial results for Q1 2025, which included significant charges related to its B-21 bomber program [1][3]. Financial Performance - Northrop Grumman reported revenue of $9.47 billion for Q1 2025, reflecting a 7% year-over-year decline and falling short of consensus estimates by $480 million [3]. - The company incurred a pretax charge of $477 million associated with manufacturing updates for the B-21 bomber program, attributed to inflationary factors by the CEO [3]. - Following the announcement of these results, Northrop Grumman's stock price dropped by $67.25 per share, or 12.66%, closing at $464.08 per share on April 22, 2025 [3].